Cargando…

Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma

Natural killer (NK) cells are phenotypically and functionally diverse lymphocytes that recognize and kill cancer cells. The susceptibility of target cancer cells to NK cell-mediated cytotoxicity depends on the strength and balance of regulatory (activating/inhibitory) ligands expressed on target cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Saheli, Sabhachandani, Pooja, Ravi, Dashnamoorthy, Potdar, Sayalee, Purvey, Sneha, Beheshti, Afshin, Evens, Andrew M., Konry, Tania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735063/ https://www.ncbi.nlm.nih.gov/pubmed/29312292 http://dx.doi.org/10.3389/fimmu.2017.01736

Ejemplares similares

Interaction Kinetics with Transcriptomic and Secretory Responses of CD19 CAR Natural Killer Cell Therapy in CD20 Resistant Non-Hodgkin Lymphoma
por: Ravi, Dashnamoorthy, et al.
Publicado: (2019)

T Cell Dynamic Activation and Functional Analysis in Nanoliter Droplet Microarray
por: Sarkar, Saheli, et al.
Publicado: (2015)

Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel
por: McDonald, J. Tyson, et al.
Publicado: (2018)

Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel
por: McDonald, J. Tyson, et al.
Publicado: (2018)

Oncogenic Integration of Nucleotide Metabolism via Fatty Acid Synthase in Non-Hodgkin Lymphoma
por: Ravi, Dashnamoorthy, et al.
Publicado: (2021)

An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors
por: Ravi, Dashnamoorthy, et al.
Publicado: (2022)

Scaffold-mediated switching of lymphoma metabolism in culture
por: Bhatt, Rachana, et al.
Publicado: (2022)

Quantifying the efficacy of checkpoint inhibitors on CD8(+) cytotoxic T cells for immunotherapeutic applications via single-cell interaction
por: Sullivan, Matthew Ryan, et al.
Publicado: (2020)

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma
por: Chen, Benjamin J., et al.
Publicado: (2019)

Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
por: Chiu, Jodi, et al.
Publicado: (2018)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models
por: Beheshti, Afshin, et al.
Publicado: (2019)

Natural killer cell T-cell lymphoma (nasal type), a rare and aggressive type of non-Hodgkin's lymphoma: Case report
por: Kandel, Devraj, et al.
Publicado: (2023)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study
por: Besson, Caroline, et al.
Publicado: (2007)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines
por: Li, Yutao, et al.
Publicado: (2021)

Occurrence of Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Hermansky-Pudlak Type 2 Syndrome Is Associated to Natural Killer and Natural Killer T Cell Defects
por: Lorenzi, Luisa, et al.
Publicado: (2013)

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma
por: Jiang, Peijia, et al.
Publicado: (2022)

Live single cell functional phenotyping in droplet nano-liter reactors
por: Konry, Tania, et al.
Publicado: (2013)

Hodgkin Reed–Sternberg-Like Cells in Non-Hodgkin Lymphoma
por: Parente, Paola, et al.
Publicado: (2020)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

On the origin of giant cells in Hodgkin lymphoma
por: Rengstl, Benjamin, et al.
Publicado: (2014)

Adoptive T-cell therapy for Hodgkin lymphoma
por: Ho, Carrie, et al.
Publicado: (2021)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma
por: Marini, Cecilia, et al.
Publicado: (2023)

Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
por: Bhalla, Kavita, et al.
Publicado: (2018)

Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma
por: Rodday, Angie Mae, et al.
Publicado: (2021)

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
por: Khan, Muhammad Rahil, et al.
Publicado: (2018)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
por: Hartmann, Sylvia, et al.
Publicado: (2021)

A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma
por: Beheshti, Afshin, et al.
Publicado: (2017)

Health-related quality of life in Hodgkin lymphoma: a systematic review
por: Linendoll, Nadine, et al.
Publicado: (2016)

Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
por: Tsang, Vivian
Publicado: (2012)

Hodgkin's Lymphoma Presenting as Alopecia
por: Garg, Sunny, et al.
Publicado: (2012)

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
por: Mangano, Chiara, et al.
Publicado: (2019)

Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
por: Bhalla, Kavita, et al.
Publicado: (2018)

Langerhans Cell Histiocytosis Followed by Hodgkin's Lymphoma
por: Park, IK Soo, et al.
Publicado: (2012)

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

Primary T-Cell Non-Hodgkin Lymphoma of the Vagina
por: Herraiz, J. L., et al.
Publicado: (2015)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
por: Katsin, Mikalai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhjsjj6q21pnptpcfjr5e7j5av